Dr. Christina M. Clay, MD

Dr. Clay practices at Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care.

Dr. Clay's NPI, 1326029042, was assigned on November 9, 2005. Dr. Clay graduated from Feinberg School of Medicine in 1985. Dr. Clay holds New Jersey license 25MA10885600.

Dr. Clay's primary practice is Cooper University Hospital, at 1 Cooper Plaza, Camden, NJ 08103 in Camden County. The practice phone is (856) 342-2000.

Dr. Clay's primary practice is Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care. Dr. Clay is also affiliated with Virtua Mount Holly Hospital. The medical group on file is Cooper University Physicians. Dmand AI also links Dr. Clay to 1 more hospital, 1 hospice, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clay practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Clay's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Clay is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Clay's licenses on file in 5 states: New Jersey, California, Massachusetts, Pennsylvania and Ohio.

Dmand AI lists chronic anemia, chronic embolism thrombosis, chronic kidney disease, deep vein thrombosis (DVT), fluid and electrolyte imbalances, immune deficiency disease, joint pain and muscle disease among the conditions Dr. Clay treats.

CMS data shows 415 Medicare services from Dr. Clay across 6 procedure codes in 2024, for 218 Medicare patients. Medicare paid $28,748 for them.

CMS counts 218 Medicare patients who saw Dr. Clay in 2024. The largest group is 65 to 74, with 78 patients. 74% of them have high blood pressure, and 72% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Clay's median patient age at 56, with 75% women.

In 2024, Dr. Clay wrote 943 Medicare Part D claims for 164 patients. 75% of them were for generic drugs. CMS names the drug for 725 of them, across 22 drugs with 11 or more claims each, at $886,642 in total drug cost. In 2023, CMS named 657 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Clay for performance year 2024, reported as part of a group. Dr. Clay accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Clay as offering telehealth.

Dmand AI links 3 papers to Dr. Clay, published from 2019 to 2024. Dr. Clay's most frequent co-authors are Clint Andrew Badger, DO, Brandyn Robert Chinn, DO and Brian Philip Gable, MD.

CMS Open Payments shows 385 general payments to Dr. Clay from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 43% of the total. McKesson Specialty Care Distribution Corp. paid the most, $6,030.

Dmand AI lists 1 award for Dr. Clay, most recently CMS Stage 1 EHR in 2013.

Dr. Clay graduated from Feinberg School of Medicine in 1985.

Dr. Clay is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.